Enko Welcomes Tim Hassinger as the Company’s Newest Board Member
24 July 2024 - 10:00AM
Business Wire
Tim Hassinger, CEO, President, and Chairman of the board of
directors, Intelinair (Indianapolis), has joined Enko Chem, Inc.,
as the agricultural discovery company’s newest board member.
This press release features multimedia. View
the full release here:
https://www.businesswire.com/news/home/20240724249811/en/
Tim Hassinger, CEO, President, and
Chairman of the board of directors, Intelinair, has joined Enko
Chem, Inc., as the agricultural discovery company’s newest board
member. (Photo: Business Wire)
Hassinger brings nearly forty years of experience in the
agricultural industry. Prior to being named CEO and President of
Intelinair in January 2022, he was CEO of Dow AgroSciences, the
Indianapolis-based agricultural subsidiary of The Dow Chemical
Company, where he had held crop protection, commercial sales,
supply chain, marketing, and management roles over 33 years. He
then moved to become CEO at Lindsay Corporation in Omaha, Neb.
Intelinair, Hassinger’s current firm, provides whole field
insights via hi-res aerial imagery and machine learning, to inform
agronomic management decisions via its interactive AGMRI platform.
He also currently serves on the Board of Directors of AGDATA and
Hatch for Hunger.
Tim Hassinger said: “I am looking forward to working with Enko’s
accomplished team and contributing to the strategic plan for the
next phase of the company. I am impressed by the speed of the
R&D, the results, and Enko’s potential to bring sustainable
farm outputs around the globe.”
Marijn Dekkers, Chairman of Enko and Chairman of Novalis
LifeSciences, commented: “We are very excited to have Tim join our
board. His wide global ag perspective will be invaluable in helping
Enko in its development of novel data-driven products for farmers
to protect their crops from pests, weeds and disease.”
About Enko®
Enko (Enko Chem Inc.) designs safe and sustainable solutions to
farmers’ biggest crop threats today, from pest resistance to new
diseases. By applying the latest drug discovery and development
approaches from pharma to plants, Enko is bringing an innovation
model to agriculture and meeting farmers’ evolving needs. Founded
in 2017, and led by a team of proven scientists, entrepreneurs, and
agriculture industry veterans, Enko is backed by investors
including the Bill & Melinda Gates Foundation, Anterra Capital,
Finistere Ventures, Nufarm, Novalis LifeSciences, Germin8 Ventures,
TO Ventures Food, and Rabo Food & Agri Innovation Fund. Enko is
headquartered in Mystic, Connecticut, USA. For more information,
visit www.enko.ag
Enko’s Cautionary Statement Regarding Forward-Looking
Statements
This press release contains forecasts, projections, goals,
plans, and other forward-looking statements. Such forward-looking
statements are based on Enko's assumptions, estimates, outlook, and
other judgments made in light of information available at the time
of preparation of such statements and involve both known and
unknown risks and uncertainties. Accordingly, plans, goals, and
other statements may not be realized as described, and actual
financial results, success/failure or progress of development, and
other projections may differ materially from those presented
herein. The forward-looking statements are neither promises nor
guarantees, and you should not place undue reliance on these
forward-looking statements because they involve known and unknown
risks, uncertainties, and other factors, many of which are beyond
Enko’s control and that could cause actual results to differ
materially from those expressed or implied by these forward-looking
statements. Enko does not intend to update any forward-looking
statements appearing herein in the event of changing circumstances
or otherwise, and such statements are current only as of the date
they are made.
©Enko Chem, Inc., 62 Maritime Drive, Mystic, CT 06355 USA
View source
version on businesswire.com: https://www.businesswire.com/news/home/20240724249811/en/
Enko Karin Whiting-Burgess Communications Director
Karin.Whiting-Burgess@enko.ag